Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Left Ventricular Assist Device
80%
Heart Failure
52%
Dilated Cardiomyopathy
36%
Continuous-flow Left Ventricular Assist Device (CF-LVAD)
33%
Acute Decompensated Heart Failure
33%
Peripartum Cardiomyopathy
31%
Cardiac Transplantation
30%
Patients with Heart Failure
27%
Heart Failure Patients
23%
HeartMate II
23%
Heart Transplantation
22%
Transplantation
20%
Exercise Training
19%
Hazard Ratio
18%
Left Ventricular Function
18%
Clinical Outcomes
17%
Precision Medicine
16%
95% Confidence Interval
15%
Left Ventricular Assist Device Implantation
14%
Quality of Life
14%
Mechanical Circulatory Support
14%
First Degree Relatives
14%
Antibody-mediated Rejection
14%
Destination Therapy
14%
Left Ventricular Ejection Fraction
14%
Proband
13%
Single Center
13%
Heart Transplant Recipients
12%
Bridge to Transplantation
11%
Orthotopic Heart Transplantation
11%
Heart Transplant
11%
Centrifugal Flow
11%
Left Ventricular Assist Device Support
11%
Clinical Course
11%
Cardiac Allograft
10%
VO2peak
10%
Self-management
10%
Cardiac Allograft Vasculopathy
10%
Pump Thrombosis
10%
Magnetically Levitated
9%
Medical Therapy
9%
Human Heart
9%
Hospitalization
9%
Soluble Fibrin
9%
Driveline
9%
Gene Expression Profiling
9%
Multi-parameter
9%
Bleeding
9%
Pregnancy-associated Cardiomyopathy
8%
Axial-flow Pump
8%
Medicine and Dentistry
Left Ventricular Assist Device
100%
Congestive Heart Failure
89%
Heart Transplantation
36%
Heart Graft
29%
Dilated Cardiomyopathy
24%
Peripartum Cardiomyopathy
22%
Apoplexy
18%
Assisted Circulation
17%
Hazard Ratio
16%
Exercise
14%
Myocardial Disease
14%
Heart Left Ventricle Ejection Fraction
13%
Quality of Life
12%
Thrombosis
12%
Etiology
10%
Ventricular Assist Device
9%
Gene Expression Profiling
9%
Systolic Heart Failure
8%
Infection
8%
Orthotopic Heart Transplantation
8%
Outpatient
8%
Diseases
8%
Morbidity
7%
Implant
7%
Reoperation
7%
Cardiovascular System
7%
Cardiogenic Shock
7%
Acute Graft Rejection
7%
Adverse Event
7%
Driveline Infection
7%
Personalized Medicine
7%
Adrenergic Receptor Blocking Agent
6%
Bleeding
6%
Hemodynamic
6%
Allograft
6%
Blood Pressure
6%
Device Therapy
6%
Remote Patient Monitoring
6%
Heart Ventricle Remodeling
6%
Cancer
6%
Single-Photon Emission Computed Tomography
6%
Disease Severity
6%
All Cause Mortality
6%
New York Heart Association Class
6%
Ejection Fraction
5%
Exercise Test
5%
Heart Muscle Ischemia
5%
Gene Expression
5%
Prevalence
5%
Graft Survival
5%